Tag: CBT > International: Page 17

Legislation and Regulation

Costa Rica’s Congress Passes Medical Cannabis Legalization Bill

The legislation would also legalize the cultivation of industrial hemp.

March 2, 2022

International

Tilray Launches Medical Cannabis Products in Malta

The company’s medical cannabis division completes its first sales with products now available across the country.

February 17, 2022

Finance

Cansativa Group Closes $15M Series B to Become the 'Amazon' of Cannabis for Europe

The largest medical cannabis distributor in Germany readies for expansion into the recreational market.

February 16, 2022

Indoor Grow Cannabis Cultivation Facility

Indoor Innovations

Working with PIPP Horticulture helps Cannerald utilize its full indoor space and boost efficiencies in cultivation.

February 14, 2022

Interviews & Opinion

Safety and Culture at Forefront of Cannabis Social Club vs. Dispensary Debate

Will U.S.-style dispensaries emerge supreme, or will social clubs be the dominant adult-use retail model?

February 10, 2022

Mergers and Acquisitions in the Cannabis Market

Flora Growth’s Strategic Future

CEO Luis Merchan considers human capital, distribution, and revenue when targeting deals, says political reform will accelerate plans.

February 9, 2022

International

Tilray Consolidates Global Medical Offering Into Tilray Medical

The new division brings together the legacy Tilray and Aphria medical businesses; includes expanded offerings in Canada.

February 8, 2022

International

UPDATE: Thailand Moves to Decriminalize Cannabis, Setting Bar in Asia

The country of roughly 70 million could influence reform amongst its Southeast Asia neighbors.

February 8, 2022

International

Flora Growth Pursues Research on Cannabinoid-Based COVID-19 Treatment in Colombia

The cultivation company wants to research its patent-pending treatment to gauge “all the potential mechanisms of cannabinoids in preventing infection from the SARS-CoV-2 (COVID-19) virus.”

February 7, 2022

International

Tilray Expands Medical Cannabis Product Offering in Australia

In addition to a newly branded and GMP-certified whole flower available for patients, Tilray launches online medical cannabis education platform.

January 25, 2022

Interviews & Opinion

Flora Growth’s Strategic Future

CEO Luis Merchan considers human capital, distribution and revenue when targeting deals, says political reform will accelerate plans.

December 27, 2021

Mergers and Acquisitions in the Cannabis Market

Tilray’s Takeover

Following its blockbuster merger with Aphria, Tilray continues its M&A streak and grows its revenue and geographic reach considerably.

December 15, 2021